StonvexLoading…
StonvexStonvexStonvexCore line items from COF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.41B | $8.06B | $5.62B | $3.33B |
Operating Income | $2.70B | $2.28B | $182.00M | $-4.20B |
Net Income | $2.17B | $2.45B | $319.00M | $-2.87B |
EPS (Diluted) | $3.34 | $4.03 | $0.23 | $-6.74 |
Total Assets | $682.90B | $669.01B | $661.88B | $658.97B |
Total Liabilities | $570.64B | $555.39B | $548.06B | $548.01B |
Cash & Equivalents | $79.26B | $62.09B | $58.53B | $61.58B |
Free Cash Flow OCF − CapEx | $5.47B | $26.14B | $18.75B | $9.99B |
Shares Outstanding | 615.86M | 625.10M | 635.73M | 639.52M |